New Collection of Crude Drugs in Chinese Pharmacopoeia 2010 Ⅰ.Callicarpa Linn. and Related Items

作     者：DAN Yang1, QIAN Zhong-zhi2, LIU Yan-ze1, ZHOU Guo-ping3, PENG Yong1, XIAO Pei-gen1 1. Institute of Medicinal Plant Development, Chinese Academy of Medical Science, Beijing 100193, China 2. China Pharmacopoeia Committee, Beijing 100061, China 3. Jiangxi Provincial Institute for Food and Drug Control, Nanchang 330046, China 

作者机构：Institute of Medicinal Plant DevelopmentChinese Academy of Medical ScienceBeijing 100193China China Pharmacopoeia CommitteeBeijing 100061China Jiangxi Provincial Institute for Food and Drug ControlNanchang 330046China 

出 版 物：《Chinese Herbal Medicines》 (中草药(英文版))

年 卷 期：2010年第02卷第4期

页      面：272-288页

学科分类：100703[医学-生药学] 1007[医学-药学(可授医学、理学学位)] 10[医学] 

主　　题：Callicarpa formosana Callicarpa kwangtungensis Callicarpa Linn. Callicarpa macrophylla Chinese patent medicine Chinese Pharmacopoeia quality assessment 

摘      要：Callicarpa Linn. (beautyberry) is one of the major genera in Verbenaceae, about 20 of which are medicinal plants. Beautyberry, called Zizhu in China, is a generic name of those species and largely used as hemostatic medicine. The Chinese Pharmacopoeia 2010 has admitted three new crude drugs from the genus of Callicarpa Linn. including Callicarpae Macrophyllae Folium, Callicarpae Caulis et Folium, and Callicarpae Formosanae Folium for the first time since the 1977 version of the Chinese Pharmacopoeia. In order to better understand these new crude drugs, we systematically described their bibliography, admission reasons, botanical identification, chemistry, and pharmacology. Several other species, out of national regulations but intensively studied and widely used, are also covered in this review.